Hedge Fund - Commodore Capital
Xenon Pharmaceuticals Inc. (XENE)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q2 (2025-06-30) | $94,682,500 | 6.68% | 3,025,000 | $32.62 |
| 2 | 2025 - Q1 (2025-03-31) | $78,003,750 | 5.75% | 2,325,000 | $37.97 |
| 3 | 2024 - Q4 (2024-12-31) | $107,408,000 | 7.87% | 2,740,000 | $41.35 |
| 4 | 2024 - Q3 (2024-09-30) | $106,299,000 | 6.64% | 2,700,000 | $40.32 |
| 5 | 2024 - Q2 (2024-06-30) | $107,388,831 | 7.33% | 2,754,266 | $39.97 |
| 6 | 2024 - Q1 (2024-03-31) | $93,323,489 | 6.24% | 2,167,793 | $46.00 |
| 7 | 2023 - Q4 (2023-12-31) | $99,848,546 | 8.72% | 2,167,793 | $35.33 |
| 8 | 2023 - Q3 (2023-09-30) | $63,025,200 | 7.36% | 1,845,000 | $37.40 |
| 9 | 2023 - Q2 (2023-06-30) | $71,032,500 | 7.98% | 1,845,000 | $39.75 |
| 10 | 2023 - Q1 (2023-03-31) | $66,032,550 | 10.05% | 1,845,000 | $36.94 |
| 11 | 2022 - Q4 (2022-12-31) | $65,419 | 9.85% | 1,659,111 | $36.42 |
| 12 | 2022 - Q3 (2022-09-30) | $57,577,000 | 9.25% | 1,594,932 | $35.95 |
| 13 | 2022 - Q2 (2022-06-30) | $48,518,000 | 10.25% | 1,594,932 | $30.24 |
| 14 | 2022 - Q1 (2022-03-31) | $36,764,000 | 8.21% | 1,202,613 | $29.94 |
| 15 | 2021 - Q4 (2021-12-31) | $34,056,000 | 7.88% | 1,090,126 | $29.88 |
| 16 | 2021 - Q3 (2021-09-30) | $8,854,000 | 2.33% | 579,432 | $17.38 |
| 17 | 2021 - Q2 (2021-06-30) | $6,076,000 | 2.11% | 326,336 | $18.43 |
| 18 | 2021 - Q1 (2021-03-31) | $5,395,000 | 2.14% | 301,392 | $16.95 |
| 19 | 2020 - Q4 (2020-12-31) | $7,188,000 | 3.9% | 467,368 | $11.70 |
The displayed share prices are average quarterly stock market prices.